Literature DB >> 33849838

[Speckle-type POZ protein up-regulates c-Jun protein expression and promotes proliferation and invasion of renal carcinoma cells].

L Wu1, K Yu1, Y Cue2, X Zhu3, Z Yang3, J Ma4.   

Abstract

OBJECTIVE: To investigate the effect of speckle-type POZ protein (SPOP) on proliferation, apoptosis, migration and invasion of renal cell carcinoma (RCC) and explore the potential mechanisms.
OBJECTIVE: Renal carcinoma cell lines (786-O, A704, and Caki-2) cultured in vitro were transfected with a SPOP-overexpressing plasmid, and the changes in proliferation of the cells were detected using colony formation and MTT assay; TUNEL assay was used to assess apoptosis of the cells. The changes in migration and invasion abilities of the cells were examined using wound healing assay and Transwell assay. The mRNA and protein levels of SPOP and c-Jun in the transfected cells were measured using real-time PCR and Western blotting.
OBJECTIVE: SPOP over-expression obviously promoted the proliferation, migration and invasion of 786-O, A704 and Caki-2 cells (P < 0.05). Compared with the control cells, 786-o and Caki-2 cells over-expressing SPOP exhibited significantly lowered apoptosis rates (P < 0.05). The results of real-time PCR demonstrated that the transfected cells did not show obvious changes in the mRNA level of c-Jun, but the protein expressions of SPOP and c-jun increased significantly as shown by Western blotting (P < 0.05).
OBJECTIVE: SPOP can promote proliferation, migration, and invasion and suppress apoptosis of renal carcinoma cells possibly by promoting the expression of c-Jun.

Entities:  

Keywords:  apoptosis; c-Jun; invasion; migration; proliferation; renal carcinoma; speckle-type POZ protein

Mesh:

Substances:

Year:  2021        PMID: 33849838      PMCID: PMC8075795          DOI: 10.12122/j.issn.1673-4254.2021.03.19

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  23 in total

1.  Speckle-type POZ protein is negatively associated with malignancies and inhibits cell proliferation and migration in liver cancer.

Authors:  Yuping Huang; Ning Tan; Deshui Jia; Ying Jing; Qifeng Wang; Zhe Li; Jiwei Zhang; Li Liu; Jinjun Li; Zhiao Chen; Xianghuo He
Journal:  Tumour Biol       Date:  2015-07-10

2.  Kidney cancer: On target - inhibiting SPOP in ccRCC.

Authors:  Louise Stone
Journal:  Nat Rev Urol       Date:  2016-10-04       Impact factor: 14.432

3.  C-jun activation in acquired cystic kidney disease and renal cell carcinoma.

Authors:  Mototsugu Oya; Shuji Mikami; Ryuichi Mizuno; Ken Marumo; Makio Mukai; Masaru Murai
Journal:  J Urol       Date:  2005-08       Impact factor: 7.450

4.  SPOP, ZEB-1 and E-cadherin expression in clear cell renal cell carcinoma (cc-RCC): Clinicopathological and prognostic significance.

Authors:  Ola A Harb; Mariem A Elfeky; Basant Sh El Shafaay; Heba F Taha; Gamal Osman; Ibtsam Shehta Harera; Loay M Gertallah; Doaa Metwaly Abdelmonem; Ahmed Embaby
Journal:  Pathophysiology       Date:  2018-05-18

Review 5.  Systemic Treatment of Metastatic Clear Cell Renal Cell Carcinoma in 2018: Current Paradigms, Use of Immunotherapy, and Future Directions.

Authors:  Aly-Khan A Lalani; Bradley A McGregor; Laurence Albiges; Toni K Choueiri; Robert Motzer; Thomas Powles; Christopher Wood; Axel Bex
Journal:  Eur Urol       Date:  2018-10-13       Impact factor: 20.096

6.  Prostate cancer-associated mutation in SPOP impairs its ability to target Cdc20 for poly-ubiquitination and degradation.

Authors:  Fei Wu; Xiangpeng Dai; Wenjian Gan; Lixin Wan; Min Li; Nicholas Mitsiades; Wenyi Wei; Qiang Ding; Jinfang Zhang
Journal:  Cancer Lett       Date:  2016-10-22       Impact factor: 8.679

7.  SPOP promotes tumor progression via activation of β-catenin/TCF4 complex in clear cell renal cell carcinoma.

Authors:  Wencai Zhao; Jiancheng Zhou; Zhuo Deng; Yang Gao; Yongyi Cheng
Journal:  Int J Oncol       Date:  2016-07-06       Impact factor: 5.650

8.  Renal cell carcinoma recurrences and metastases in primary non-metastatic patients: a population-based study.

Authors:  Saeed Dabestani; Andreas Thorstenson; Per Lindblad; Ulrika Harmenberg; Börje Ljungberg; Sven Lundstam
Journal:  World J Urol       Date:  2016-02-05       Impact factor: 4.226

9.  Speckle-type POZ protein as a diagnostic biomarker in renal cell carcinoma.

Authors:  Ashutosh Chauhan; Shalmoli Bhattacharyya; Rani Ojha; Arup K Mandal; Shrawan K Singh
Journal:  J Cancer Res Ther       Date:  2018 Jul-Sep       Impact factor: 1.805

10.  Acquisition of epithelial-mesenchymal transition is associated with Skp2 expression in paclitaxel-resistant breast cancer cells.

Authors:  Q Yang; J Huang; Q Wu; Y Cai; L Zhu; X Lu; S Chen; C Chen; Z Wang
Journal:  Br J Cancer       Date:  2014-03-18       Impact factor: 7.640

View more
  1 in total

1.  CUL3/SPOP complex prevents immune escape and enhances chemotherapy sensitivity of ovarian cancer cells through degradation of PD-L1 protein.

Authors:  Min Dong; Min Qian; Zhengyi Ruan
Journal:  J Immunother Cancer       Date:  2022-10       Impact factor: 12.469

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.